Name,Category,Begin Date,End Date,Note
Back Pain Workup,Milestones,2023-03-10,,
Spine MRI,Biomarker Assess,2023-03-15,,Multiple vertebral lesions
Breast Mass Discovered,Milestones,2023-03-18,,5cm right breast mass
Core Biopsy Breast,Biomarker Assess,2023-03-22,,Invasive ductal carcinoma
ER/PR/HER2 Testing,Biomarker Assess,2023-03-25,,Triple negative confirmed
PD-L1 Testing,Biomarker Assess,2023-03-25,,CPS score 25 - strongly positive
CT Chest/Abdomen/Pelvis,Biomarker Assess,2023-03-28,,Liver and lung mets confirmed Stage IV
BRCA Testing,Biomarker Assess,2023-04-01,,BRCA2 mutation detected
Spine Radiation Palliative,Line 1 treatment,2023-04-05,2023-04-14,Pain control 10 fractions
Keytruda/Abraxane 1L,Line 1 treatment,2023-04-17,2023-10-30,Pembrolizumab plus nab-paclitaxel
3-Month Restaging CT,Biomarker Assess,2023-07-20,,Partial response 40% reduction
6-Month Restaging CT,Biomarker Assess,2023-10-20,,Stable disease
Disease Progression,Complications,2023-11-15,,New liver lesions on CT
Olaparib 2L,Line 2 treatment,2023-11-25,2024-05-20,PARP inhibitor for BRCA2
Restaging Shows Response,Biomarker Assess,2024-02-25,,Liver mets shrinking
Brain MRI for Headaches,Biomarker Assess,2024-05-15,,Brain metastases found
Brain Progression,Complications,2024-05-15,,CNS involvement
Whole Brain Radiation,Line 2 treatment,2024-05-22,2024-06-05,WBRT 10 fractions
Trodelvy 3L,Line 3 treatment,2024-06-15,2024-10-15,Sacituzumab govitecan
